Abstract
There is good evidence that the kynurenine pathway (KP) and one of its products, quinolinic acid (QUIN) play a role in the pathogenesis of neurological diseases. Monocytic cells are known to be the major producers of QUIN. However, macrophages have the ability to produce approximately 20 to 30-fold more QUIN than microglia. The molecular origin of this difference has not been clarified yet. Using unstimulated and IFN-y-stimulated cultures of human fcetal microglia and adult macrophages, we assayed mRNA expression of 8 key enzymes of the KP using RT-PCR and QUIN production using GC-MS. We found that after stimulation with IFN-y microglia producedde novo20-fold less QUIN than macrophages. This quantitative difference in the ability to produce QUIN appears to be associated with a lower expression of 3 important enzymes of the KP in microglia: indoleamine 2,3-dioxygenase (IDO), kynureninase (KYNase) and kynurenine hydroxylase (KYN(OH)ase). These results suggest that activated infiltrating macrophages are the most potent QUIN producers during brain inflammatory diseases with playing a lesser role.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.P. Heyes, K. Saito, S.P. Markey, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acidBiochem. J.283, 633–635 (1992).
B.J. Brew, L. Pemberton, L. Evans, M. Heyes, Quinolinic acid production by macrophages infected with demented and non-demented isolates of HIVClin. Neuropathol. 12, Sl (1993).
G.J. Guillemin, B.J. Brew, Implications of the kynurenine pathway and quinolinic acid in Alzheimer’s disease (review), Redox Rep. in press, (2002).
P. Guidetti, P. Hemachandra Reddy, D.A., Tagle, R. Schwarcz, Early kynurenergic impairment in Huntington’s Disease and in a transgenic animal modelNeurosci. Lett.283, 233–235 (2000).
D.A. Bender, G.M. McCreanor, The preferred route of kynurenine metabolism in the ratBiochitn. Biophys. Acta717, 56–60 (1982).
N.P. Botting, Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolismChem. Soc. Reviews24, 401–412 (1995).
G. Curzon, Brain tryptophan. Normal and disturbedcontrol Adv.Exp.Med.Bio1.39827–34 (1996).
F. Moroni, Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites [In Process Citation]Eur. J. Pharmacol.375, 87–100 (1999).
T.W. Stone, Neuropharmacology of quinolinic and kynurenic acidsPharmacol. Rev.45, 309–379 (1993).
I.P. Lapin, I.B. Prakhie, I.P. Kiseleva, Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and miceJ. Neural. Transm.54, 229–238 (1982).
C.L. Eastman, Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell lineBrain Res.495, 225–231 (1989).
G. Melillo, M.C. Bosco, T. Musso, L. Varesio, lmmunobiology of picolinic acidAdv. Exp. Med. Biol.398, 135–141 (1996).
R. Schwarcz, W.O. Jr. Whetsell, R.M. Mangano, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brainScience219, 316–318 (1983).
M.P. Heyes, C.L. Achim, C.A. Wiley, E.O. Major, K. Saito, S.P. Markey, Human microglia convert Ltryptophan into the neurotoxin quinolinic acidBiochem. J.320: 595–597 (1996).
M.G. Espey, O.N. Chernyshev, J.J. Reinhard, M.A. Namboodiri, C.A. Colton, Activated human microglia produce the excitotoxin quinolinic acidNeuroreport8, 431–434 (1997).
G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protectionJ. Neurochem.78, 1–13 (2001).
D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Kohler, A.M. Cesura, Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cellsJ. Neurochem.66, 996–1004 (1996).
D. Alberati-Giani, A.M. Cesura, Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulat¨®rsAmino Acids14, 251–255 (1998).
M.P. Heyes, K. Saito, C.Y. Chen, M.G. Proescholdt, T.S. Jr. Nowak, J. Li, K.E. Beagles, M.A. Proescholdt, M.A. Zito, K. Kawai, S.P. Markey, Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activationJ Neurochem69, 1519–1529 (1997).
M.P. Heyes, C.Y. Chen, E.O. Major, K. Saito, Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell typesBiochem. J.326, 351–356 (1997).
L.A. Pemberton, S.J. Kerr, G. Smythe, B.J. Brew, Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alphaJ. interferon Cytokine Res.17, 589–595 (1997).
C.U. Kloss, G.W. Kreutzberg, G. Raivich, Proliferation of ramified microglia on an astrocyte monolayer: char acterization of stimulatory and inhibitory cytokinesJ. Neurosci. Res.49, 248–254 (1997).
D. Giulian, T.J. Baker, Characterization of ameboid microglia isolated from developing mammalian brainJournal of Neuroscience6, 2163–2178 (1986).
S.J. Kerr, P.J. Armati, L.A. Pemberton, G. Smythe, B. Tattam, B.J. Brew, Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophagesNeurology49, 1671–1681 (1997).
G. Guillemin, F.D. Boussin, J. Croitoru, M. Franck-Duchenne, R. Le Grand, F. Lazarini, D. Dormont, Obtention and characterization of primary astrocyte and microglial cultures from adult monkey brainsJ. Neurosci. Res.49, 576–591 (1997).
G.A. Smythe, S.J. Kerr, G.J. Guillemin, B. J. Brew, Quantification of picolinic acid using electron capture negative ion mass spectrometryAnal. Biochem.submitted, (1998).
F. Villinger, D. Hunt, A. Mayne, M. Vuchetiv, H. Findley, and A.A. Ansari, Qualitative and quantitative studies of cytokines synthetized and secreted by non-human primate peripheral blood mononuclear cellsCytokine5. 169–179 (1993).
T.W. Stone, Endogenous neurotoxins from tryptophanToxicon39, 61–73 (2001).
A.L. Cunningham, H. Naif, N. Saksena, G. Lynch, J. Chang, S. Li, R. Jozwiak, M. Alali, B. Wang, W. Fear, A. Sloane, L. Pemberton, 13. Brew, HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotypeJ. Leukoc. Biol.62, 117–125 (1997).
F. Du, W. Schmidt, E. Okuno, R. Kido, C. Kohler, R. Schwarcz, Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampusJ Comp Neurol321, 477–487 (1992).
M. Tamburin, M. Mostardini, L. Benatti, Kynurenine aminotransferase I (KATI) isoform gene expression in the rat brain: an in situ hybridization studyNeuroreport10, 61–65 (1999).
R. Kapoor, E. Okuno, R. Kido, V. Kapoor, Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cordNeuroreport8, 3619–3623 (1997).
J. Urenjak, Obrenovitch, Neuroprotective potency of kynurenic acid against excitotoxicityNe T.P.uroreport11, 1341–1344 (2000).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Guillemin, G.J., Smith, D.G., Smythe, G.A., Armati, P.J., Brew, G.J. (2003). Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0135-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4939-6
Online ISBN: 978-1-4615-0135-0
eBook Packages: Springer Book Archive